Ep 53: Cradle CEO Stef van Grieken on the State of AI x Bio and Selling SaaS to Pharma
53:07
Share
2024/12/3
Vital Signs with Jacob Effron and Nikhil Krishnan
Request Transcript
Frequently requested episodes will be transcribed first
Chapters
Intro
Cradle Bio's Rapid Growth and AI Innovations
The State of AI in Drug Development
Challenges and Opportunities in AI Biospace
Cradle Bio's Approach to Biologics Development
AI's Role in Hit Identification and Lead Optimization
Cradle Bio's Software and Customer Base
Inside Cradle Bio's Lab and Data Strategy
Future Directions and Protein Modalities
Navigating the Pharma SaaS Market
Challenges in Adopting New Protocols
Software vs. Service Companies
Gaps in Drug Development
Advances in AI and Bio
Future of Drug Discovery
Advice for Aspiring Bio Entrepreneurs
Quickfire
Shownotes
Transcript
No transcript made for this episode yet, you may request it for free.
